BlackRock, Inc. 13D and 13G filings for FibroGen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
2,409,650 2.400% |
-4,795,650 (-66.56%) |
Filing |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
7,205,300 7.300% |
71,562 (+1.00%) |
Filing |
| 2023-02-06 12:37 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
7,133,738 7.600% |
488,196 (+7.35%) |
Filing |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
6,645,542 7.200% |
-1,252,060 (-15.85%) |
Filing |
| 2021-01-29 09:56 am Purchase |
2020-12-31 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
7,897,602 8.700% |
1,270,603 (+19.17%) |
Filing |